AstraZeneca is facing new questions today after a highly unusual reprimand from a board overseeing the company’s clinical vaccine trials.The company is scrambling to respond to allegations that it used misleading data when claiming its vaccine was 79 percent effective against COVID-19 symptoms. Nick Schifrin breaks down the latest with epidemiologist Dr. Jennifer Nuzzo of John Hopkins University.
Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts